<p>This Project Grant award of $549,904.00 from the Defense Health Agency is intended to fund research under the Military Medical Research and Development program (CFDA 12.420) to evaluate reductions in hippocampal volume related to blast exposure and their effect on memory function. The research will be conducted by the Salisbury Foundation For Research And Education, located in Salisbury, NC. The award period is from September 30, 2023 to September 29, 2026.</p>
This federal Project Grant award, with a funding amount of $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on innovative research addressing critical health challenges. The specific project, titled "IN VIVO NEUROEPIGENETICS IN COMBAT VETERANS WITH...
This $4,626,921 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant was awarded on August 1, 2025 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization in Bethesda, Maryland. The research aims to elucidate the role of the...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...
This $6,699,872.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the "MICROGLIAL BREAKTHROUGHS IN LONGEVITY, AGING, AND SENESCENCE AFTER TBI (MICROBLAST)" research initiative at the University of Pittsburgh. The 4-year award, starting on Sep 30, 2024, aims to conduct advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public by...
Veterans Medical Research Foundation Of San Diego will use a $749,985 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to examine associations between traumatic brain injury history and other risk factors on Alzheimer's disease and related dementias in military veterans. As a non-profit organization, the Foundation will leverage its experience conducting medical research to enhance veteran health outcomes. For this award...
The federal Project Grant award of $5,954,349.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The award was made to Virginia Commonwealth University (VCU), which is collaborating with the Palo Alto Veterans Institute for Research (Pavir) and the Richmond Institute for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,460,695.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to support the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" research project. The award period runs from September 1, 2025 to August 31, 2028. The funded research aims to...